Anne Wojcicki’s nonprofit TTAM Research Institute secured 23andMe’s assets in a $305 million deal, outbidding Regeneron and committing to stringent privacy protections and continued data use for scientific research. This acquisition preserves 23andMe’s consumer genetic services and research potential under a mission-driven organization led by the company’s founder.